Related Experiment Videos
The new emphasis in cancer control
Journal of the National Cancer Institute
|March 1, 1985
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.
British journal of cancer·2005
Improved survival in primary nonmetastatic pediatric osteosarcoma of the extremity.
Clinical orthopaedics and related research·2005
Cancer risk and diet in India.
Journal of postgraduate medicine·2003
Molecular targets for nutrients involved with cancer prevention.
Nutrition and cancer·2002
Examining the role of extrachromosomal DNA in lung cancer.
Journal of the National Cancer Institute·2026
Differential impact of lymphocytes on radiation response in autochthonous vs transplant murine sarcomas.
Journal of the National Cancer Institute·2026
Nitrate and nitrite intake and risk of colorectal cancer: a population-based cohort study.
Journal of the National Cancer Institute·2026
The joint association of clonal hematopoiesis of indeterminate potential and biological aging with cancer risk among 332,911 individuals.
Journal of the National Cancer Institute·2026
Electroacupuncture for acute gastrointestinal symptoms during chemotherapy for colorectal cancer: a randomized clinical trial.
Journal of the National Cancer Institute·2026
Cancer incidence and the risk for multiple primary cancers in neurofibromatosis type 1.
Journal of the National Cancer Institute·2026
NIR-Activated Enteric Prodrug Microparticles for Bioimaging-Guided Chemotherapy of Colorectal Cancer.
ACS applied materials & interfaces·2026
Protective effect of the bee bread on cadmium-induced testicular toxicity in rats.
Veterinary research forum : an international quarterly journal·2026
Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experience.
Clinical and translational radiation oncology·2026
Efficacy and Safety of Sintilimab in Combination With Anlotinib and Chemoradiotherapy as First-Line Treatment for Driver Gene-Negative Oligometastatic Non-small Cell Lung Cancer: A Real-World Cohort Study.
Dose-response : a publication of International Hormesis Society·2026